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Background: Lactic acid bacteria (LAB) can be isolated from traditional milk products. LAB that secrete substances
that inhibit pathogenic bacteria and are resistant to acid, bile, and pepsin but not vancomycin may have potential
in food applications.
Results: LAB isolated from a range of traditional fermented products were screened for the production of
bacteriocin-like inhibitory substances. A total of 222 LAB strains were isolated from fermented milk products
in the form of fresh curds, dried curds, and ghara (a traditional flavor enhancer prepared from whey), and
fermented cocoa bean. Eleven LAB isolates that produced antimicrobial substances were identified as
Lactococcus lactis, Lactobacillus plantarum, and Pediococcus acidilactici strains by biochemical methods and
16S rDNA gene sequencing. Of these, the cell-free supernatant of Kp10 (P. acidilactici) most strongly inhibited
Listeria monocytogenes. Further analysis identified the antimicrobial substance produced by Kp10 as
proteinaceous in nature and active over a wide pH range. Kp10 (P. acidilactici) was found to be catalase-
negative, able to produce β-galactosidase, resistant to bile salts (0.3%) and acidic conditions (pH 3), and
susceptible to most antibiotics.
Conclusion: Traditionally prepared fermented milk products are good sources of LAB with characteristics
suitable for industrial applications. The isolate Kp10 (P. acidilactici) shows potential for the production of
probiotic and functional foods.
Keywords: Lactic acid bacteria, Pediococcus acidilactici, Bacteriocin-like inhibitory substance, Listeria
monocytogenes, Fermentation, IdentificationBackground
The screening of microorganisms isolated from naturally
occurring processes is the most common method of
obtaining strains useful for industrial applications. This
holds true for lactic acid bacteria (LAB), which are used
worldwide to produce a variety of fermented foods [1].
Because LAB have been used in food production for
centuries without posing any health risks, they are* Correspondence: arbarif@biotech.upm.edu.my
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distribution, and reproduction in any mediumdesignated as generally regarded as safe (GRAS) micro-
organisms [2].
LAB are normally found in nutrient-rich environments
and are able to grow in most raw foods. These bacteria
are fastidious and require fermentable carbohydrates,
amino acids, fatty acids, salts, and vitamins for growth
[3]. Because of their metabolic properties, LAB play an
important role in the food industry, contributing signifi-
cantly to flavor, texture, and frequently the nutritional
value of foods [4].
Because of the rapid rise and spread of multi-resistant
bacterial pathogens, new methods are needed to combattral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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spread of pathogenic bacteria; however, many antibiotics
are broad-spectrum drugs that kill bacterial species in-
discriminately [5]. Bacteriocins have a relatively narrow
spectrum of killing activity, and some can be consid-
ered pathogen-specific designer drugs. Given the di-
versity of bacteriocins produced in nature, it may be
a relatively simple task to identify bacteriocins effect-
ive against specific human pathogens [5]. In addition,
bacteriocin use may reduce the need for chemical
additives in food and minimize the intensity of food pro-
cessing techniques, contributing to the production of
more healthful foods [6].
In recent years, attention has been focused on LAB
from different sources that produce bacteriocins that
are considered safe as food biopreservatives and can
be degraded by gastrointestinal proteases [7]. These
probiotic compounds have been used in a variety of
industrial applications relevant to both human and
animal health without producing side effects. There is
an ongoing need to identify new strains with useful
characteristics. Therefore, the main objective of this
study was to isolate and characterize LAB that pro-
duce bacteriocin-like inhibitory substances (BLIS)
from traditionally prepared milk products (e.g., fresh
curds, dried curds, and ghara) and locally fermented
cocoa beans. These fermented products do not use
starter cultures; fermentation is the result of wild
flora present in the surrounding environment. Wild
LAB strains represent a natural reservoir of strains
not exposed to any industrial selection and are poten-
tial probiotics and bacteriocin producers [8]. In this
study we identified and characterized LAB strains that
produce high BLIS levels for possible applications in
the food industry.Table 1 Morphological, biochemical characteristics and antim
Fresh curds
Pg Cam Pak Ky
Cam4 Cam5 Pak1 Pak7
No. of LAB isolates
(cultured in MRS and M17)
10 8 26 20
No. of isolates showing
antimicrobial activity
0 2 2 0
Cell morphology ND Bacilli Bacilli ND
Gram stain reaction ND + + ND
Catalase activity ND - - ND




ND 276.51c 276.51c 26.78 a 26.78a ND 88
Positive reaction (+), negative reaction (−), not detected (ND).
Values with different superscript letters (a, b, c, d) are significantly different.Results
Isolation of BLIS-producing strains
A total of 222 LAB strains were isolated from nine test
samples (Table 1). After preliminary identification, 11 of
these strains were found to produce antimicrobial sub-
stances. All 11 isolates were gram-positive, catalase-
negative, and able to ferment glucose and produce acid.
Both cocci and bacilli were identified. The isolates Kp8
and Kp10 showed the highest antimicrobial activity
(888.56 AU/mL).
Characterization of isolates with API 50 CHL
The carbohydrate fermentation patterns of the 11 iso-
lates were determined by using the API 50 CHL micro-
identification system (Table 2). The isolates Gh1, C22,
and C13 were able to hydrolyze ribose, d-xylose, galact-
ose, glucose, fructose, mannose, n-acetyl-glucosamine,
amygdalin, esculin, arbutin, salicin, cellobiose, maltose,
lactose, trehalose, starch, gentiobiose, and gluconate.
However, mannitol and sucrose were hydrolyzed by Gh1
but not by C22 or C13. The isolates Kp8 and Kp10 were
able to hydrolyze glycerol, l-arabinose, ribose, d-xylose,
galactose, glucose, fructose, mannose, mannitol, n-
acetyl-glucosamine, esculin, salicin, cellobiose, gentio-
biose, and d-tagatose. The isolates Com4, Pak1, Com5,
C6, C7, and Pak7 were able to hydrolyze, ribose, galact-
ose, glucose, fructose, mannose, mannitol, n-acetyl-glu-
cosamine, amygdalin, arbutin, esculin, salicin, cellobiose,
maltose, lactose, melibiose, sucrose, trehalose, melezi-
tose, and gentiobiose but differed in their ability to
metabolize glycerol, sorbose, rhamnose, sorbitol, α-me-
thyl-d-mannoside, α-methyl-d-glucoside, raffinose, tura-
nose, d-tagatose, l-fucose, d-arabitol, and gluconate. To
identify the isolates, their carbohydrate metabolism pat-
terns were analyzed using the API database (Table 3).icrobial activity of LAB isolates
Dried curds Ghara Fermented cocoa beans
Kp Sat Kbo Gh1 C
Kp8 Kp10 C6 C7 C13 C22
20 40 40 10 48
2 0 0 1 4
Cocci ND ND Cocci Bacilli Bacilli Cocci Cocci
+ ND ND + +
- ND ND - -
+ ND ND + +
8.56 d 888.56d ND ND 115.21b 26.78a 26.78a 26.78a 26.78a
Table 2 Biochemical profiles of LAB isolates
LAB isolates
Gh1 Com4 Pak1 Kp8 Com5 Kp10 C22 C6 C7 C13 Pak7 Gh1 Com4 Pak1 Kp8 Com5 Kp10 C22 C6 C7 C13 Pak7
0 Control - - - - - - - - - - -
1 Glycerol - + + + + + - - + - + 26 Salicin + + + + + + + + + + +
2 Erythritol - - - - - - - - - - - 27 Celiobiose + + + + + + + + + + +
3 D-Arabinose - - - - - - - - - - - 28 Maltose + + + - + - + + + + +
4 L- Arabinose - - - + - + - - - - - 29 Lactose + + + - + - + + + + +
5 Ribose + + + + + + + + + + + 30 Melibiose - + + - + - - + + - +
6 D-Xylose + - - + - + + - + + - 31 Sucrose + + + - + - - + + - +
7 L-Xylose - - - - - - - - - - - 32 Trehalose + + + - + - + + + + +
8 Adonitol - - - - - - - - - - - 33 Inulin - - - - - - - - - - -
9 ß-Methyl-D-Xyloside - - - - - - - - - - - 34 Melezitose - + + - + - - + + - +
10 Galactose + + + + + + + + + + + 35 Raffinose - + - - + - - + + - -
11 Glucose + + + + + + + + + + + 36 Starch + - - - - - + - - + -
12 Fructose + + + + + + + + + + + 37 Glycogen - - - - - - - - - - -
13 Mannose + + + + + + + + + + + 38 Xylitol - - - - - - - - - - -
14 Sorbose - - - - - - - + + - - 39 Gentibiose + + + + + + + + + + +
15 Rhamnose - - - - - - - - + - - 40 Turanose - - - - - - - + + - -
16 Dulcitol - - - - - - - - - - - 41 D-Lyxose - - - - - - - - - - -
17 Inositol - - - - - - - - + - - 42 D-Tagatose - - - + - + - - + - -
18 Mannitol + + + + + + - + + - + 43 D-Fucose - - - - - - - - - - -
19 Sorbitol - - - - - - - + + - - 44 L- Fucose - - - - - - - - + - -
20 α-Methyl-D-Mannoside - - - - - - - + + - - 45 D-Arabitol - + + - + - - - - - +
21 α-Methyl-D-Glucoside - - - - - - - - + - - 46 L- Arabitol - - - - - - - - - - -
22 N-Acetyl-Glucosamine + + + + + + + + + + + 47 Gluconate + + - - + - + + + + -
23 Amygdalin + + + - + - + + + + + 48 2-Keto-Gluconate - - - - - - - - - - -
24 Arbutin + + + - + - + + + + + 49 5-Keto-Gluconate - - - - - - - - - - -
25 Esculin + + + + + + + + + + +


















Table 3 Analysis of carbohydrate metabolism (ABI 50 CHL) and 16S rDNA sequence analysis (BLASTN) of BLIS-
producing LAB isolates
Sources Strain Species % Accuracy (50 CHL ) % Similarity (BLASTN)
Ghara Gh1 Lactococcus lactis 99.9 98
Fresh curd (market) Com4 Lactobacillus plantarum 99.6 97
Com5 Lactobacillus plantarum 99.6 99
Pak1 Lactobacillus plantarum 99.5 99
Pak7 Lactobacillus plantarum 99.5 99
Dried curd Kp8 Pediococcus acidilactici 99.6 95
Kp10 Pediococcus acidilactici 99.6 99
Fermented cocoa beans C22 Lactococcus lactis 99.6 99
C6 Lactobacillus plantarum 99.9 98
C7 Lactobacillus plantarum 99.9 98
C13 Lactococcus lactis 99.6 99
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PCR analysis of genomic DNA of the 11 isolates revealed
bands that were the predicted size of 1.5 kb (Figure 1).
The nucleotide sequences of these PCR products were
compared with other 16S rDNA sequences in the Gen-
Bank database by BLASTN (Table 3).
Phylogenetic analysis of isolate Kp10
A phylogenetic tree was generated by using the
neighbour-joining method after aligning the nucleotide
sequence of isolate Kp10 (accession number: JN592051)
with sequences in the GenBank database (Figure 2). The
isolate Kp10 formed a distinct cluster with Pediococcus
acidilactici, supported by a bootstrap value of 100%.
Physiological and biochemical characterization of isolate
Kp10 (P. acidilactici)
The isolate Kp10 (P. acidilactici) was selected for further
analysis based on its ability to produce high amounts of




1 2 3 4 5 6
Figure 1 Agarose gel electrophoresis of PCR products amplified using
Kp10, Gh1, Com4, Com5, Pak1, Pak7, C6, C7, C13, and C22, respectively; lancatalase-negative coccus that was arranged in tetrads
(Table 4). Kp10 demonstrated the ability to grow in the
presence of 2% NaCl and within a temperature range of
30°C to 45°C.
As shown in Table 5, Kp10 (P. acidilactici) was sus-
ceptible to 18 antibiotics (penicillin G, erythromycin,
ceftriaxone, amikacin, ciprofloxacin, norfloxacin, chlor-
amphenicol, cefuroxime sodium, tetracycline, nalidixic
acid, ampicillin, gentamycin, nitrofurantoin, sulfameth-
oxazole/trimethoprim, vancomycin, novobiocin, kanamy-
cin, and oxytetracycline), and resistant to five antibiotics
(lincomycin, colistin sulphate, bacitracin, polymixin B,
and cefamandole).β-galactosidase activity
The isolate Kp10 (P. acidilactici) produced blue/green
colonies on M17 agar supplemented with X-gal and
IPTG, which confirmed the ability to secrete β-
galactosidase.01 12117 8 9 M 
16S rDNA primers. M, GeneRuler DNA Ladder; lanes 1–11 are Kp8,
e 12, negative control (no template).
Figure 2 Phylogenetic relationship of Kp10 with related species based on partial 16S rDNA gene sequence analysis. The phylogenetic
tree was constructed using the neighbour-joining method (CLC Sequence Viewer 6.5.2). The numbers at the nodes are bootstrap confidence
levels (percentage) from 1,000 replicates. The scale bar represents 0.120 substitutions per nucleotide position. Reference sequences were obtained
from the GenBank nucleotide sequence database.
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The ability of Kp10 (P. acidilactici) to tolerate bile
salts is shown in Figure 3. Percent survival was
>95% after 1 h incubation but was reduced to 89%
after 4 h.Table 4 Characteristics of isolate Kp10
Characteristics Kp10 (Pediococcus acidilactici)










Growth in M17 broth:
With 0.5% NaCl +
With 2% NaCl +
With 4% NaCl -
With 6.5% NaCl -








Positive results (+), negative results (-).Tolerance to low pH
The ability of Kp10 (P. acidilactici) to tolerate acidic
conditions is shown in Figure 3. Percent survival at pH 3
was >97% after 1 to 3 h incubation.
Effect of pH and enzymes on BLIS activity
The effect of pH on Kp10 BLIS activity is shown in Table 6.
BLIS was stable after a 1-h incubation at pH 2 to 9, but ac-
tivity was considerably reduced at pH 10 and not detect-
able at pH 11. The effect of various enzymes on BLIS
activity is shown in Table 7. Kp10 BLIS activity was
retained in the presence of pepsin, α-amylase, and catalase
but not in the presence of proteinase K or trypsin.
Discussion and conclusions
In recent years much attention has focused on
bacteriocin-producing LAB isolated from various
sources, because bacteriocins are considered safe as food
biopreservatives and can be degraded by gastrointestinal
proteases [9]. However, LAB species present in trad-
itional foods of Southeast Asian countries have not been
widely studied [10]. In this study, 11 LAB strains isolated
from traditional fermented milk products and cocoa
beans from rural areas of Malaysia and Iran were found
to produce antimicrobial substances. These LAB isolates
were characterized, and two of the strains (Kp8 and
Kp10) produced substances active against Listeria mono-
cytogenes (888.56 AU/mL).
Phenotypic characterization based on sugar fermenta-
tion reveals biochemical properties of the microorgan-
isms [11] but may not always provide a strong basis for
LAB identification [12]. Although 16S rDNA sequence
analysis is a powerful technique for identifying microor-
ganisms and determining phylogenetic relationships
[13], further analysis is needed for positive identification
[14]. Therefore, we used both of these methods to
Table 5 Growth inhibition of P. acidilactici Kp10 by disc diffusion method
Antibiotic Inhibition zone diameter
Disc content Size (mm) ≤15 mm (R) 16–20 mm (I) ≥21 mm (S)
Penicillin G 2 Units 24 (0) +
Penicillin G 10 Units 26.5 (0.07) +
Erythromycin 15 μg 32 (0) +
Erythromycin 10 μg 30 (0) +
Ceftriaxone 30 μg 33.08 (1.31) +
Lincomycin 10 μg 0 (0) +
Colistin sulphate 10 μg 0 (0) +
Streptomycin 10 μg 18.63 (0.88) +
Amikacin 30 μg 24.83 (0.25) +
Cloxacillin 5 μg 19 (0) +
Ciprofloxacin 10 μg 30 (0) +
Norfloxacin 10 μg 24 (0) +
Chloramphenicol 30 μg 32.28 (0.4) +
Cefuroxime sodium 30 μg 34.25 (0.35) +
Tetracycline 30 μg 29.5 (0.07) +
Tetracycline 10 μg 24 (0) +
Nalidixic acid 30 μg 31 (0) +
Ampicillin 25 μg 32 (0) +
Gentamycin 10 μg 22.5 (0.71) +
Gentamycin 30 μg 28 (0) +
Mecillinam 25 μg 19.72 (0.4) +
Nitrofurantoin 300 μg 30 (0) +
Sulfamethoxazole/ trimethoprim 25 μg 31 (0.14) +
Vancomycin 30 μg 24.75 (0.04) +
Bacitracin 10 μg 0 (0) +
Novobiocin 30 μg 34.5 (0.07) +
Kanamycin 30 μg 24.15 (0.21) +
Neomycin 30 μg 20 (0) +
Polymixin B 300 Units 0 (0) +
Oxytetracycline 30 μg 21 (0) +
Cefamandole 30 μg 12 (0) +
For all experiments coefficient of variation was ≤5 %. Results (zone of inhibition) are expressed as mean (SD).
R, resistant; I, intermediate; S, susceptible.
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ribose, galactose, glucose, fructose, mannose, n-acetyl-
glucosamine, esculin, salicin, cellobiose and gentiobiose.
Three different LAB species (Lactococcus lactis, Lactoba-
cillus plantarum, and Pediococcus acidilactici) were
identified using the API 50 CHL system and 16S rDNA
analysis. Identification of Kp10 as P. acidilactici was
confirmed by phylogenetic analysis (Figure 2).
In addition, β-galactosidase activity, tolerance to bile
salts and acid conditions, and antimicrobial activity were
to evaluate the probiotic properties of Kp10 (P. acidilac-
tici). The isolate was able to grow in the presence of 2%NaCl, but growth was inhibited by 3% NaCl. Homofer-
mentative LAB are more resistant than heterofermenta-
tive LAB to NaCl [15]. Pediococci strains are
homofermentative, and tolerance to pH, temperature,
and NaCl is species- and strain-dependent [16]. Bacterial
cells cultured in high salt concentrations experience a
loss of turgor pressure, which affects cell physiology, en-
zyme and water activities, and metabolism [17]; however,
some bacteria overcome this effect by regulating osmotic
pressure on both sides of the cell membrane [18].
Optimum temperature can also be used to differentiate
among LAB strains [19]. Our results indicated that Kp10
Figure 3 Tolerance of the isolate Kp10 (P. acidilactici) to acidic
conditions and bile salts. Results are expressed as mean and
standard deviation; tests were performed in triplicate.
Table 7 Effect of enzymes on BLIS activity
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with the findings of Ronald [20].
LAB are found in many natural environments; how-
ever, antibiotic resistance in these bacteria is a growing
concern [21]. Thus, sensitivity to antibiotics must be
determined before LAB strains can be used in food pro-
duction [22]. Antibiotic-resistant strains can be detri-
mental to the health of humans and animals [21],
because they are capable of transferring antibiotic resist-
ance genes to pathogenic bacteria [23], which can con-
taminate raw food products such as meat or milk.Table 6 Effect of pH on BLIS activity












ND, not detected.Data on the antibiotic susceptibility of Pediococcus
spp. isolated from food are limited. Penicillin G, imipe-
nem, gentamicin, netilmicin, erythromycin, clindamycin,
rifampin, chloramphenicol, daptomycin, and ramoplanin
are generally active against Pediococcus species [24-27].
However, susceptibility is thought to be species-
dependent. We found that isolate Kp10 (P. acidilactici)
was susceptible to ß-lactam antibiotics (penicillin G and
ampicillin), as well as erythromycin, chloramphenicol,
nitrofurantoin, and tetracycline. In contrast, previous
studies have reported that LAB are often resistant to
commonly used antibiotics such as β-lactams, cephalos-
porins, aminoglycosides, quinolone, imidazole, nitrofur-
antoin, and fluoroquinolones [23,28]. ß-lactams, which
are bactericidal, are the most widely used class of anti-
microbial agent because of their broad spectrum of ac-
tion and excellent safety profile. ß-lactams inhibit
bacteria cell wall synthesis and have a lethal effect on
gram-positive bacteria. Erythromycin is a macrolide anti-
biotic with a range of action and efficacy similar to that
of penicillin. Macrolides, which are bacteriostatic, bind
to ribosomes to block protein synthesis and are effective
against gram-positive microorganisms [29]. The ration-
ale for this contradictory finding with those of Halami,
et al. [28] and Herreros et al. [23] is not known. Lacto-
bacillus and Lactococcus were previously reported to be
susceptible to β-lactam antibiotics [29], which is in
agreement with the findings of this study. It is possible
that the reports of Halami et al. and Herreros et al. re-
ferred to LAB in general, whereas the present study spe-
cifically analyzed the species P. acidilactici.
The isolate Kp10 (P. acidilactici) was susceptible to a
gram-negative antibiotic (nalidixic acid) and aminoglyco-
sides (amikacin, kanamycin, neomycin, and strepto-
mycin). In contrast, Zhou et al. [30] and Temmerman
et al. [26] reported that most Lactobacillus, Entero-
coccus, and Pediococcus strains used as probiotics are re-
sistant to gram-negative and aminoglycoside antibiotics.
Thus, susceptibility to gram-negative antibiotics may be
specific for this LAB species.
Vancomycin, an inhibitor of cell wall synthesis, is an
important antibiotic because it is the last agent broadly
effective against multi-drug resistant pathogens [29].
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making it potentially useful for applications in the food
industry [31]. Kp10 (P. acidilactici) was also susceptible
to sulfonamide. Resistance to this antibiotic is caused by
mutations in the gene encoding dihydropteroate syn-
thase or by acquisition of plasmid-borne genes carrying
sulfonamide-resistant forms of the enzyme [32].
Our results also showed that Kp10 (P. acidilactici)
produced blue/green colonies when grown on M17 agar
supplemented with X-gal and IPTG, demonstrating β-
galactosidase activity. β-galactosidase is involved in
lactose digestion and is used in the production of
lactose-free milk. β-galactosidase–producing bacteria
may also be potential probiotics to reduce lactose in-
tolerance [33].
Mean bile concentration in the human gastrointestinal
tract is 0.3% (w/v), with a residence time of about 4 h
[34]. Therefore, we tested tolerance to bile salts at a con-
centration of 0.3%, which revealed 11% survival after
4 h. Bile salts interact with bacterial cell membranes,
which are composed of lipids and fatty acids, inhibiting
growth and killing many bacteria. The protonated (non-
dissociated) form of bile salt exhibits toxicity by a mech-
anism similar to that of organic acids. This is involves
intracellular acidification and collapse of the proton
motive force, which in turn, inhibits the nutrient trans-
port. However, some LAB strains are able to hydrolyze
bile salts with bile salt hydrolase [35].
Resistance to low pH is one of the major criteria for
selecting strains for probiotic applications [36]. Survival
of Kp10 (P. acidilactici) at pH 3 exceeded 97%, suggest-
ing its potential for use as a probiotic.
Several strains of P. acidilactici isolated from the intes-
tine of healthy dairy cows and characterized using methods
similar to those used in the present study were found to in-
hibit Escherichia coli. [37]. The authors reported that P.
acidilactici was resistant to acid and bile salts, indicting the
ability to survive and colonize in the intestine. In the
present study, we found that Kp10 (P. acidilactici) was ac-
tive against the pathogen L. monocytogenes. It is interesting
to note that P. acidilactici from two different agricultural
sources (intestine of dairy cows and a traditional milk
product) showed promising prophylactic properties.
We found that the BLIS from Kp10 (P. acidilactici)
was stable in a wide range of pH (2–9), suggesting that
its antimicrobial activity was not due to the pH of the
cell-free supernatant. The reduced activity at high pH
was probably due to denaturation of the protein. A simi-
lar result was also observed for an antimicrobial com-
pound produced by Lactococcus lactis, which was active
at the pH range 2 to 10 and completely inactivated at
pH 12 [38].
Since bacteriocins are proteinaceous substances, they
must be sensitive to at least one proteolytic enzyme [39].Therefore, bacteriocins can be identified in part by ex-
posure to proteolytic enzymes [40]. We found proteo-
lytic enzyme treatment reduced the activity of the
antimicrobial compound secreted by Kp10 (P. acidilac-
tici). However, activity was not reduced by catalase, indi-
cating that H2O2 was not responsible for microbial
inhibition, or α-amylase activity, indicating that the com-
pound was not glycosylated, which is characteristic of
most bacteriocins [41]. Complete inactivation activity was
observed after treatment with proteinase K and trypsin, in
accordance with a report by Albano et al. [42] of pediocin
PA-1 activity [43]. Treatment with pepsin did not alter the
antimicrobial activity of the BLIS in this study; however,
proteolytic enzymes do not always reduce the antimicro-
bial activity of a bacteriocin [44]. Stability in the presence
of a proteolytic enzyme could be due to unusual amino
acids in the bacteriocin structure or cyclic N-terminal or
C-terminal protected peptides [45].
We conclude that isolate Kp10 (P. acidilactici) is a po-
tential probiotic that may exert beneficial positive effects
on intestinal flora, because the strain is tolerant of bile
salts (0.3%) and acidic conditions (pH 3). To better
understand its potential as a probiotic, future studies are
needed to characterize the interactions of this P. acidi-
lactici strain to the intestinal mucosal epithelium.Methods
Isolation of lactic acid bacteria
Fresh curds (three varieties), dried curds (four varieties),
ghara (one variety), and fermented cocoa beans were
obtained from family-owned businesses in rural areas of
Malaysia and Iran. Ghara is a traditional flavor enhancer
that is popular in northern Iran. It is prepared by incuba-
ting a blend of flour with whey at room temperature for
several days. Food samples (25 mL or 25 g, depending on
type of sample) were mixed with 225 mL de Man Rogosa
Sharpe (MRS) medium (Merck, Darmstadt, Germany).
After a 24-h incubation at 30°C, cultures were serially
diluted (10-fold) in buffered Andrade peptone water (Bio-
Chemika, India). To prepare agar plates, MRS and M17
agar (Merck, Darmstadt, Germany) were supplemented
with 0.01% (w/v) sodium azide to inhibit the growth of
gram-negative bacteria. Diluted samples (100 μL) were
spread on agar plates and incubated in anaerobic condi-
tions at 30°C for 24 to 72 h. The isolates were evaluated by
cell morphology, Gram stain reaction, and biochemical
and physiological characteristics.Physiological and biochemical characterization
Cell morphology and Gram stain
Gram staining was carried out according to the routine
procedure, and cell morphology was examined by light
microscopy.
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Catalase activity was determined by adding a drop of 3%
(v/v) H2O2 on a colony. Immediate effervescence was
indicated a positive reaction.
Glucose fermentation test
Nutrient agar was prepared with 1% (w/v) of glucose
and 0.004% (w/v) bromocresol purple (Sigma) as a pH
indicator. Cultures (10 μL) were spread on the prepared
agar. A yellow zone around the culture after 24-h incu-
bation at 37°C indicated acid production.
Effect of NaCl concentration on growth
The isolates were inoculated (1% v/v) into M17 broth
containing different concentrations of NaCl (0.5%, 2%,
4%, 6.5%, or 10% [w/v]) and bromocresol purple and
incubated at 37°C. After 48 h, growth was evaluated,
indicated by a color change from purple to yellow.
Effect of temperature on growth
The isolates were inoculated (1% v/v) into M17 broth
containing bromocresol purple and incubated for 48 h at
different temperatures (4°C, 10°C, 30°C, 35°C, 37°C, 45°C,
or 60°C). During the incubation, growth was evaluated
at time intervals, indicated as a color change from purple
to yellow.
Effect of low pH on growth
The isolates (1 mL) were inoculated into 9 mL sterile
M17 broth, and the pH was adjusted to 3 using 0.5 N
HCl. During incubation, growth was monitored as
optical density at 650 nm using a spectrophotometer
(Perkin Elmer, Lambda 25, USA). After incubation for 0,
1, 2, 3, or 4 h, viable microorganisms were enumerated
using the pour plate technique. Diluted cultures (100
μL) were mixed with cooled M17 agar, poured into
plates, and incubated at 37°C for 24 to 48 h. The num-
ber of colonies was determined using a colony counter
and compared with the control (0 h) to determine acid
tolerance [46].
Percent survival was calculated as follows:
Percent survival ¼ log cfu tf=log cfu tið Þ  100%
ð1Þ
where tf is the incubation time and ti is 0 h (control).
Effect of bile salts on growth
Bile tolerance of the isolates was determined by the vi-
able count method [47]. The isolates (1 mL) were inocu-
lated into 9 mL sterile M17 broth enriched with 0.3%
(w/v) bile salts (Oxoid) and incubated at 37°C. Growth
was monitored as optical density at 650 nm using a
spectrophotometer. After incubation for 0, 1, 2, 3, or4 h, viable microorganisms were enumerated using the
pour plate technique. The number of colonies was deter-
mined using a colony counter and compared with the
control (0 h) to determine bile salt tolerance. Percent
survival was calculated using Equation 1.
Antibacterial susceptibility testing
Susceptibility to 24 antibiotics was determined by using
the disc diffusion method [48]. Single colonies were
inoculated into M17 broth and incubated at 37°C for
24 h. A sterile cotton wool swab dipped into the bacter-
ial suspension was used to spread bacteria evenly on the
surface of M17 agar plate.
Commercially available antibiotics discs (Oxide) con-
taining penicillin G (2 units), erythromycin (10 μg), cef-
triaxone (30 μg), colistin sulphate (10 μg), streptomycin
(10 μg), amikacin (30 μg), norfloxacin (10 μg), chloram-
phenicol (30 μg), tetracycline (10 μg), nalidixic acid
(30 μg), ampicillin (25 μg), gentamycin (30 μg), mecilli-
nam (25 μg), nitrofurantoin (300 μg), sulfamethoxazole/
trimethoprim (25 μg), vancomycin (30 μg), kanamycin
(30 μg), neomycin (30 μg), lincomycin (10 μg), cloxacil-
lin (5 μg), ciprofloxacin (10 μg), cefuroxime sodium
(30 μg), bacitracin (10 μg), or novobiocin (30 μg) were
carefully placed on the surface of the dried agar plates to
ensure uniform contact between the disc and agar. The
plates were then incubated at 30°C for 24 h.
Inhibition zones (including the disc diameter) were
measured, and isolates were categorized as sensitive (≥
21 mm), intermediate (16–20 mm), or resistant (≤
15 mm), as previously described [29,49].
β-galactosidase activity
The method described by Karasova et al. [50] was used
to test for β-galactosidase activity. The isolate was incu-
bated at 37°C for 24 h on an MRS agar plate containing
0.01% X-gal (5-bromo-4-chloro-3-indolyl β-D-galacto-
pyranoside, Vivantis, Malaysia) and 0.1 mM IPTG (iso-
propyl β-D-1-thiogalactopyranoside, Vivantis) dissolved
in dimethyl sulfoxide.
Identification of isolates using API 50 CHL
API 50 CHL strips (API systems, bioMérieux, France)
were used to characterize the isolates, according to the
manufacturer’s instructions. The inoculated strips were
incubated at 30°C, and the reactions were observed after
48 h. The API database (bioMérieux SA) and accom-
panying computer software were used to interpret the
results. Readings were taken after a 48-h incubation at
30°C. Growth on a particular substrate changed the
color of the medium from violet to yellow, which was
scored on a 5-point scale (intense yellow = 5). A score
≥3 was considered a positive result. The test was per-
formed in triplicate.
Abbasiliasi et al. BMC Microbiology 2012, 12:260 Page 10 of 12
http://www.biomedcentral.com/1471-2180/12/260Identification of isolates by 16S rDNA sequencing and
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The isolates were identified by 16S rDNA sequencing to
confirm the results obtained from biochemical identifi-
cation. Briefly, the procedure is as follows.
DNA extraction DNA was extracted using the method
described by Leenhouts et al. [51], with some modifica-
tions. Cells harvested from an overnight culture
(1.5 mL) were resuspended in 200 μL distilled water
containing 12 mg/mL lysozyme and incubated at 37°C
for 90 min. After adding 100 μL sodium dodecyl sulfate
(15% (w/v), the solution was mixed by gentle inversion
and incubated at 65°C for 5 to 10 min until the mixture
was clear. Ice-cold 3 M sodium acetate (300 μL, pH 5.2)
was added, and the solution was mixed gently, incubated
on ice for 10 min, centrifuged at 15,000 × g for 12 min at
4°C, and then transferred to another tube. Phenol (600
μL) was then added, and the solution was centrifuged
for 12 min at 15,000 × g at room temperature. The upper
layer containing DNA was transferred to a clean tube,
and the DNA was precipitated by incubation at −20°C
overnight with one volume of 3 M sodium acetate and
two volumes of ice-cold isopropanol. After centrifugation
at 15,000 × g at 4°C for 10 min, the supernatant was care-
fully removed by pipetting, and the DNA pellet was
washed with 1 mL ice-cold ethanol (70% v/v). To remove
the alcohol, the sample was centrifuged at 15,000 × g for
10 min. The DNA was air-dried for 15 to 30 min before
adding 40 μL 1× Tris-EDTA buffer and 2 μL RNase and
then incubated at 37°C for 15 min. The DNA was stored
at −20°C for subsequent use in experiments.
The DNA was analyzed by 0.7% (w/v) agarose gel elec-
trophoresis at a constant voltage of 75 V for 45 min until
the methylene blue dye reached approximately 10 mm
from the base of the gel.
Sequencing and phylogenetic analysis The isolates
were identified by PCR analysis using a set of primers
(27 F and 1542–1522 R) specific for bacterial 16S rDNA
[52] according to the method described by Chong et al.
[53], with a slight modification. Briefly, for hot-start
PCR, the polymerase was activated at 95°C for 5 min.
PCR was performed as follows: denaturing at 95°C for
1 min, annealing at 55°C for 1 min, and extension at 72°C
for 1 min for 30 cycles, followed by a final extension step
at 72°C for 10 min.
After agarose gel electrophoresis, the PCR products
were purified using the Wizard SV Gel and PCR Clean
Up Kit (Promega, Madison, WI, USA) according to the
manufacturer’s instructions. The PCR products were
sequenced and compared with reference sequences by
conducting a BLAST search of the GenBank database
(http://www.ncbi.nlm.nih.gov/blast/Blast.cgi). The 16SrDNA sequences were aligned using CLC Sequence
Viewer 6.5.2, and a phylogenetic tree was constructed
using the neighbour-joining method. Bootstrap resam-
pling was carried out with 1,000 replications to estimate
the confidence of tree topologies.
Antimicrobial activity test
The antimicrobial activity of the isolates was determined
by the agar well diffusion method [54] using cell-free
culture supernatants. The isolates were grown in M17
broth at 30°C for 24 h, and the cultures were centrifuged
at 12,000 × g for 20 min at 4°C (rotor model 1189, Uni-
versal 22R centrifuge, Hettich AG, Switzerland). The
supernatant (100 μL) was placed into 6-mm wells of agar
plates that were previously seeded (1% v/v) with the ac-
tively growing test strain. The plates were incubated
under optimal conditions for growth of the target micro-
organism. After 24 h, the growth inhibition zones were
measured, and antimicrobial activity (AU/mL) was deter-
mined as described by Parente et al. [55].
Effect of pH and enzymes on BLIS activity
The effect of pH on BLIS activity in the cell-free culture
supernatant was evaluated by adjusting the pH from 2 to
11 with 1 N HCl or 1 N NaOH [41]. The cell-free cul-
ture supernatant was incubated at 37°C for 1 h before
measuring BLIS activity. Sensitivity to enzymes was
determined after a 2-h incubation with proteinase K,
trypsin, pepsin, α-amylase, and catalase (final concentra-
tions, 1 and 0.1 mg/mL) (all obtained from Sigma). The
samples were incubated at 37°C, except for samples con-
taining trypsin and catalase, which were incubated at 25°C
and 37°C.
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